RECURRENT OVARY CANCER
Clinical trials for RECURRENT OVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARY CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Supercharged' immune cells tested against tough ovarian cancer
Disease control Recruiting nowThis early-stage study is testing a new type of treatment for ovarian cancer that has come back and stopped responding to standard platinum-based chemotherapy. Researchers are collecting a patient's own immune cells, boosting them in a lab to create 'memory-like' natural killer (…
Matched conditions: RECURRENT OVARY CANCER
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for Tough-to-Treat ovarian cancer: experimental drug trial opens
Disease control Recruiting nowThis early-stage study aims to find the safest and most effective dose of an experimental drug called DT2216 when given with standard chemotherapy (paclitaxel) for women with recurrent ovarian cancer that has stopped responding to platinum-based treatments. The trial will enroll …
Matched conditions: RECURRENT OVARY CANCER
Phase: PHASE1 • Sponsor: Elizabeth Stover, MD, PhD • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC